It seems there was an error, as the content you provided is marked as "undefined." Please provide specific content for summarization.
AZN has been in the news recently: AstraZeneca PLC will invest $2.5 billion to expand a research center in Beijing, increasing its workforce to 1,700 despite ongoing tax investigations in China. Additionally, AstraZeneca has entered into partnerships with Harbour BioMed and Syneron Bio for developing new therapies, potentially generating up to $7.8 billion in future milestone payments.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
